文献速递牙周病

组蛋白去甲基化酶JMJD3通过调控巨噬细胞极化抑制牙周炎牙槽骨丧失

[Histone demethylase JMJD3 inhibits alveolar bone loss by regulating macrophage polarization in periodontitis].
PubMed 文献 · Zhonghua Kou Qiang Yi Xue Za Zhi · 2024-01-01

该研究分析GEO单细胞测序数据并收集健康与牙周炎患者牙龈各9例,结合小鼠牙周炎模型及Pg-LPS刺激的巨噬细胞实验,发现牙周炎牙龈JMJD3表达升高;敲低或抑制JMJD3促进M1极化、抑制M2极化并加重小鼠牙槽骨丧失,提示JMJD3可能经调控巨噬细胞极化发挥保护作用。

要点

  • 牙周炎患者牙龈JMJD3表达显著高于健康牙龈。
  • 抑制JMJD3可促进炎症环境下巨噬细胞M1极化并抑制M2极化。
  • 抑制JMJD3加重小鼠实验性牙周炎牙槽骨丧失。

核心结论

  • JMJD3在牙周炎牙周组织中表达上调,可能通过调控巨噬细胞极化抑制牙槽骨破坏,在牙周炎症中发挥保护作用。

研究设计与样本

  • 分析GEO数据库2022年牙周组织单细胞测序结果。
  • 收集健康及牙周炎患者牙龈样本各9例,行免疫组化与RT-qPCR。
  • 构建小鼠牙周炎模型,分健康对照+生理盐水、丝线结扎+生理盐水、丝线结扎+GSK-J4组。
  • 体外用Pg-LPS模拟炎症微环境,以siRNA靶向Jmjd3及GSK-J4处理巨噬细胞。

主要发现

  • 牙周炎患者牙龈JMJD3表达(1.97±0.91)显著高于健康牙龈(1.00±0.33)(t=2.45,P=0.048)。
  • NC+LPS组Arg1表达(0.90±0.06)显著高于siRNA-Jmjd3+LPS组(0.61±0.11)(P<0.01)。
  • NC+LPS组Il-6、Il-1β、Tnf-α表达(8.50±0.16、5.56±0.20、3.44±0.16)显著低于siRNA-Jmjd3+LPS组(14.63±0.48、8.55±0.10、11.72±0.58)(均P<0.01)。
  • DMSO+LPS组Arg1、Ym1、Il-10表达(0.82±0.01、0.35±0.16、1.47±0.11)显著高于GSK-J4+LPS组(0.55±0.03、0.22±0.21、0.51±0.11)(均P<0.01)。
  • 丝线结扎+生理盐水组颊侧CEJ-ABC、腭侧CEJ-ABC及M1/M2比值(0.26±0.03、0.24±0.01 mm、0.35±0.10)显著低于丝线结扎+GSK-J4组(0.34±0.04、0.30±0.05 mm、2.50±0.58)(t=3.65,P=0.006;t=2.67,P=0.049;t=7.31,P=0.004)。

临床怎么用

  • JMJD3表达上调与牙周炎相关,可作为理解牙周炎免疫调控机制的潜在靶点。
  • 调控巨噬细胞M1/M2极化可能影响牙周炎牙槽骨破坏进程。
  • JMJD3抑制剂GSK-J4在实验中加重骨丧失,提示其临床转化需谨慎评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the expression of histone demethylase, Jumonji domain-containing protein 3 (JMJD3), in inflammatory periodontal tissues and its potential mechanism for the regulation of periodontitis. Methods: The results of single-cell sequencing of periodontal tissues published in the Gene Expression Omnibus (GEO) database in 2022 were analyzed. Nine gingival samples each from healthy and inflamed periodontal patients were collected during periodontal surgery or tooth extractions for immunohistochemical staining and real-time fluorescence quantitative PCR (RT-qPCR). Mice periodontitis models were constructed, and the experimental groups were: healthy control+saline group, silk ligation+saline group, silk ligation+GSK-J4(inhibitor of JMJD3) group. Lipopolysaccharide (LPS) derived from Porphyromonas gingivalis (Pg) (Pg-LPS) was used to mimic the periodontal inflammatory microenvironment. The macrophages were treated with small interfering RNA (siRNA) targeting Jmjd3 and the JMJD3 inhibitor GSK-J4. siRNA transfection experiments were grouped into the following: the NC group (negative control sequence transfection group), the siRNA-Jmjd3 group, the NC+LPS group, siRNA-Jmjd3+LPS group. Inhibitor experiments were grouped as dimethyl sulfoxide (DMSO) group, GSK-J4 group, DMSO+LPS group, GSK-J4+LPS group. Western blotting and immunofluorescence staining were used to explore the effects of JMJD3 on macrophage polarization and periodontal inflammation in the in vivo and in vitro settings. Results: RT-qPCR results showed that JMJD3 expression in gingival tissues of periodontitis patients (1.97±0.91) was significantly higher than that in healthy gingival tissues (1.00±0.33) (t=2.45, P=0.048). RT-qPCR results of in vitro experiments showed that either siRNA knockdown of JMJD3 or inhibition of JMJD3 using GSK-J4 promoted M1 polarization and inhibited M2 polarization in macrophages under inflammatory environment: the expression of arginase Ⅰ (Arg 1) in the NC+LPS group (0.90±0.06) was significantly higher than that in the siRNA-Jmjd3+LPS group (0.61±0.11) (P<0.01); the expression of interleukin (Il)-6, Il-1β, and tumor necrosis factor alpha (Tnf-α) in the NC+LPS group (8.50±0.16, 5.56±0.20, 3.44±0.16) were significantly lower than those in the siRNA-Jmjd3+LPS group (14.63±0.48, 8.55±0.10, 11.72±0.58) (P<0.01). The expression of Arg1, chitinase-like 3 (Ym1), Il-10 in the DMSO+LPS group (0.82±0.01, 0.35±0.16, 1.47±0.11) were significantly higher (P<0.01) than the GSK-J4+LPS group (0.55±0.03, 0.22±0.21, 0.51±0.11); the expression of Il-6, Il-1β, and Tnf-α in the DMSO+LPS group (2.03±0.13, 3.63±0.14, 4.06±0.03) were significantly lower than the GSK-J4+LPS group (2.69±0.16, 15.04±1.15, 4.36±0.10) (P<0.01). The results of the in vivo experiments revealed that inhibition of JMJD3 exacerbated bone loss in experimental periodontitis mice, increased macrophage M1 polarization, and decreased M2 polarization in inflamed periodontal tissues. The buccal cemento-enamel junction (CEJ)-alveolar bone crest (ABC), palatal CEJ-ABC, as well as the ratio of M1/M2 type macrophages were significantly lower in the silk ligation+saline group [(0.26±0.03), (0.24±0.01) mm, 0.35±0.10] than in the silk ligation+GSK-J4 group [(0.34±0.04), (0.30±0.05) mm, 2.50±0.58] (t=3.65, P=0.006; t=2.67, P=0.049; t=7.31, P=0.004; respectively). Conclusions: Single-cell sequencing as well as the in vitro and in vivo experiments verified that JMJD3 expression was upregulated in periodontitis periodontal tissues. JMJD3 may exert a protective role in periodontitis by regulating macrophage polarization, thereby inhibiting alveolar bone destruction associated with the periodontitis. 目的: 探究组蛋白去甲基化酶——含Jumonji结构域蛋白3(JMJD3)在炎症牙周组织中的表达及其对牙周炎调控的潜在机制。 方法: 分析2022年发表在基因表达综合数据库(GEO)中牙周组织单细胞测序的结果,并收集2021年6至12月同济大学附属口腔医院牙周病科和口腔颌面外科牙周手术和拔牙术中获取的健康及牙周炎患者的牙龈样本各9例,进行免疫组织化学染色、实时荧光定量PCR(RT-qPCR)。构建小鼠牙周炎模型,实验分组为:健康对照+生理盐水组、丝线结扎+生理盐水组、丝线结扎+GSK-J4(JMJD3抑制剂)组。体外使用牙龈卟啉单胞菌(Pg)来源的脂多糖(LPS)(Pg-LPS)模拟牙周炎症微环境,并使用靶向Jmjd3的小干扰RNA(siRNA)、GSK-J4分别处理巨噬细胞。siRNA转染实验分组为:阴性对照序列转染(NC)组、siRNA-Jmjd3组、NC+LPS组、siRNA-Jmjd3+LPS组。抑制剂实验分组为:二甲基亚砜(DMSO)组、GSK-J4组、DMSO+LPS组、GSK-J4+LPS组。使用蛋白质免疫印迹法、免疫荧光染色等方法探索JMJD3在体内、体外环境下对巨噬细胞极化及牙周炎症的影响。 结果: 牙周炎患者牙龈组织的JMJD3表达(1.97±0.91)显著高于健康牙龈组织(1.00±0.33)(t=2.45,P=0.048)。体外实验RT-qPCR结果显示,siRNA敲低JMJD3或使用GSK-J4抑制JMJD3均可促进炎症环境下巨噬细胞的M1极化,抑制M2极化:NC+LPS组精氨酸酶Ⅰ(Arg1)的表达(0.90±0.06)显著高于siRNA-Jmjd3+LPS组(0.61±0.11)(P<0.01);NC+LPS组白细胞介素(Il)-6、Il-1β和肿瘤坏死因子α(Tnf-α)的表达(分别为8.50±0.16、5.56±0.20、3.44±0.16)均显著低于siRNA-Jmjd3+LPS组(分别为14.63±0.48、8.55±0.10、11.72±0.58)(均P<0.01)。DMSO+LPS组Arg1、类几丁质酶3样分子(Ym1)、Il-10的表达(分别为0.82±0.01、0.35±0.16、1.47±0.11)均显著高于GSK-J4+LPS组(分别为0.55±0.03、0.22±0.21、0.51±0.11)(均P<0.01);DMSO+LPS组Il-6、Il-1β、Tnf-α的表达(分别为2.03±0.13、3.63±0.14和4.06±0.03)均显著低于GSK-J4+LPS组(分别为2.69±0.16、15.04±1.15、4.36±0.10)(均P<0.01)。体内实验结果发现,抑制JMJD3加剧了小鼠实验性牙周炎的骨丧失,增加了小鼠炎症牙周组织中巨噬细胞的M1极化,降低了M2极化。丝线结扎+生理盐水组的颊侧釉质牙骨质界至牙槽嵴顶的距离(CEJ-ABC)、腭侧CEJ-ABC及M1/M2型巨噬细胞比值[分别为(0.26±0.03)、(0.24±0.01)mm和0.35±0.10]均显著低于丝线结扎+GSK-J4组[分别为(0.34±0.04)、(0.30±0.05)mm和2.50±0.58](t=3.65,P=0.006;t=2.67,P=0.049;t=7.31,P=0.004)。 结论: 单细胞测序及体内外实验验证JMJD3在牙周炎牙周组织中表达上调,JMJD3可能通过调控巨噬细胞极化抑制牙周炎的牙槽骨破坏,从而在牙周炎症过程中发挥保护作用。.

来源:Zhonghua Kou Qiang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang RL, Lu JW, Luo LJ, et al. [Histone demethylase JMJD3 inhibits alveolar bone loss by regulating macrophage polarization in periodontitis]. Zhonghua Kou Qiang Yi Xue Za Zhi. 2024. PMID: 39036915. doi:10.3760/cma.j.cn112144-20240129-00047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。